Changes to DSM-5/ICD-10

Monday, October 02, 2017 9:55 AM | Jodi Hogue (Administrator)

As you know, the American Psychiatric Association makes minor changes to the Diagnostic and Statistical Manual (currently DSM-5) each year based on changes to the International Classification of Diseases (currently ICD-10).  Here are the changes which went into effect yesterday.  This year almost all changes are related to substance use disorders. 

DSM-5 Diagnoses and New ICD-10-CM Codes

As Ordered in the DSM-5 Classification

Download Easy-to-Print Guide

Disorder DSM-5 Recommended ICD-10-CM Code for use through September 30, 2017 DSM-5 Recommended ICD-10-CM Code for use beginning October 1, 2017
Avoidant/Restrictive Food Intake Disorder F50.89 F50.82
Alcohol Use Disorder, Mild F10.10 F10.10
Alcohol Use Disorder, Mild, in early or sustained remission F10.10 F10.11
Alcohol Use Disorder, Moderate F10.20 F10.20
Alcohol Use Disorder, Moderate, in early or sustained remission F10.20 F10.21
Alcohol Use Disorder, Severe F10.20 F10.20
Alcohol Use Disorder, Severe, in early or sustained remission F10.20 F10.21
Cannabis Use Disorder, Mild F12.10 F12.10
Cannabis Use Disorder, Mild, in early or sustained remission F12.10 F12.11
Cannabis Use Disorder, Moderate F12.20 F12.20
Cannabis Use Disorder, Moderate, in early or sustained remission F12.20 F12.21
Cannabis Use Disorder, Severe F12.20 F12.20
Cannabis Use Disorder, Severe, in early or sustained remission F12.20 F12.21
Phencyclidine Use Disorder, Mild F16.10 F16.10
Phencyclidine Use Disorder, Mild, in early or sustained remission F16.10 F16.11
Phencyclidine Use Disorder, Moderate F16.20 F16.20
Phencyclidine Use Disorder, Moderate, in early or sustained remission F16.20 F16.21
Phencyclidine Use Disorder, Severe F16.20 F16.20
Phencyclidine Use Disorder, Severe, in early or sustained remission F16.20 F16.21
Other Hallucinogen Use Disorder, Mild F16.10 F16.10
Other Hallucinogen Use Disorder, Mild, in early or sustained remission F16.10 F16.11
Other Hallucinogen Use Disorder, Moderate F16.20 F16.20
Other Hallucinogen Use Disorder, Moderate, in early or sustained remission F16.20 F16.21
Other Hallucinogen Use Disorder, Severe F16.20 F16.20
Other Hallucinogen Use Disorder, Severe, in early or sustained remission F16.20 F16.21
Inhalant Use Disorder, Mild F18.10 F18.10
Inhalant Use Disorder, Mild, in early or sustained remission F18.10 F18.11
Inhalant Use Disorder, Moderate F18.20 F18.20
Inhalant Use Disorder, Moderate, in early or sustained remission F18.20 F18.21
Inhalant Use Disorder, Severe F18.20 F18.20
Inhalant Use Disorder, Severe, in early or sustained remission F18.20 F18.21
Opioid Use Disorder, Mild F11.10 F11.10
Opioid Use Disorder, Mild, in early or sustained remission F11.10 F11.11
Opioid Use Disorder, Moderate F11.20 F11.20
Opioid Use Disorder, Moderate, in early or sustained remission F11.20 F11.21
Opioid Use Disorder, Severe F11.20 F11.20
Opioid Use Disorder, Severe, in early or sustained remission F11.20 F11.21
Sedative, Hypnotic, or Anxiolytic Use Disorder, Mild F13.10 F13.10
Sedative, Hypnotic, or Anxiolytic Use Disorder, Mild, in early or sustained remission F13.10 F13.11
Sedative, Hypnotic, or Anxiolytic Use Disorder, Moderate F13.20 F13.20
Sedative, Hypnotic, or Anxiolytic Use Disorder, Moderate, in early or sustained remission F13.20 F13.21
Sedative, Hypnotic, or Anxiolytic Use Disorder, Severe F13.20 F13.20
Sedative, Hypnotic, or Anxiolytic Use Disorder, Severe, in early or sustained remission F13.20 F13.21
Amphetamine-type Substance Use Disorder, Mild F15.10 F15.10
Amphetamine-type Substance Use Disorder, Mild, in early or sustained remission F15.10 F15.11
Amphetamine-type Substance Use Disorder, Moderate F15.20 F15.20
Amphetamine-type Substance Use Disorder, Moderate, in early or sustained remission F15.20 F15.21
Amphetamine-type Substance Use Disorder, Severe F15.20 F15.20
Amphetamine-type Substance Use Disorder, Severe, in early or sustained remission F15.20 F15.21
Cocaine Use Disorder, Mild F14.10 F14.10
Cocaine Use Disorder, Mild, in early or sustained remission F14.10 F14.11
Cocaine Use Disorder, Moderate F14.20 F14.20
Cocaine Use Disorder, Moderate, in early or sustained remission F14.20 F14.21
Cocaine Use Disorder, Severe F14.20 F14.20
Cocaine Use Disorder, Severe, in early or sustained remission F14.20 F14.21
Tobacco Use Disorder, Moderate F17.200 F17.200
Tobacco Use Disorder, Moderate, in early or sustained remission F17.200 F17.201
Tobacco Use Disorder, Severe F17.200 F17.200
Tobacco Use Disorder, Severe, in early or sustained remission F17.200 F17.201
Other (or Unknown) Substance Use Disorder, Mild F19.10 F19.10
Other (or Unknown) Substance Use Disorder, Mild, in early or sustained remission F19.10 F19.11
Other (or Unknown) Substance Use Disorder, Moderate F19.20 F19.20
Other (or Unknown) Substance Use Disorder, Moderate, in early or sustained remission F19.20 F19.21
Other (or Unknown) Substance Use Disorder, Severe F19.20 F19.20
Other (or Unknown) Substance Use Disorder, Severe, in early or sustained remission F19.20 F19.21

Please let me know if you have any questions.


Laura Groshong, LICSW, Director, Policy and Practice, Government Relations Chair

Clinical Social Work Association
The National Voice of Clinical Social Work
Strengthening IDENTITY | Preserving INTEGRITY | Advocating PARITY


            E-mail ---- 6829 Gravois Ave., St. Louis, MO 63116 --- Phone


Powered by Wild Apricot Membership Software